Abstract
A new ruthenium methylimidazole complex [Ru(MeIm)4(p-cpip)](2+) (Ru1, p-cpip=2-(4-chlorophenyl)-1H-imidazo[4,5-f][1,10]phenanthroline, MeIm=1-methylimidazole) has been synthesized and characterized. The cellular uptake, in vitro cytotoxicities, cell cycle arrest and apoptosis-inducing mechanism of this Ru(II) complex have been extensively explored by Inductively Coupled Plasma Mass Spectrometry (ICP-MS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometry, Comet assay, inverted fluorescence microscope as well as Western blotting experimental techniques. Notably, Ru1 displayed relatively high cytotoxic activity against lung cancer A549 cells and had high selectivity between tumor and normal cells in comparison with cisplatin. Further studies showed that Ru1 caused cell cycle arrest at G0/G1 phase and induced apoptosis via the mitochondrial pathway, which involved reactive oxygen species (ROS) accumulation, mitochondrial dysfunction and Bcl-2 and caspase correlative family member activation. For providing more information about the possible antitumor mechanism, the in vitro DNA binding studies have been also investigated by different spectrophotometric methods, thermal denaturation and viscosi...Continue Reading
References
Aug 17, 1982·Biochemistry·J B ChairesD M Crothers
Mar 5, 1999·Science·D C Wallace
Oct 18, 2000·Free Radical Biology & Medicine·E Cadenas, K J Davies
Aug 3, 2002·Nature Reviews. Cancer·Karen H Vousden, Xin Lu
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Jan 20, 2004·Journal of Inorganic Biochemistry·P Uma Maheswari, M Palaniandavar
May 1, 2004·Trends in Pharmacological Sciences·Lorne J HofsethCurtis C Harris
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeany M Rademaker-LakhaiJan H M Schellens
May 14, 2005·CA: a Cancer Journal for Clinicians·Irene M GhobrialAlex A Adjei
Jun 27, 2007·Journal of Pharmaceutical Sciences·Tomris Ozben
Nov 6, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hideki Mizutani
Apr 22, 2008·ChemMedChem·Ulrich SchatzschneiderStefan Wölfl
Nov 1, 2009·Metallomics : Integrated Biometal Science·Aviva LevinaPeter A Lay
Apr 8, 2011·ChemMedChem·Michelle J PisaniF Richard Keene
Aug 6, 2011·Biochimie·Xiaoxin YangQing-Yu He
Dec 14, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Linlin LiWenjie Zheng
Mar 14, 2013·Metallomics : Integrated Biometal Science·Chen QianHui Chao
Jun 24, 2014·PloS One·Ke Xu, Ping Xu
Sep 3, 2014·PloS One·Pu-Fang LiYou-Cai Xiong
Nov 13, 2014·Chemistry : a European Journal·Huaiyi HuangHui Chao
Sep 5, 2015·Chemistry : a European Journal·Leli ZengHui Chao
Citations
Jul 6, 2016·Archives of Toxicology·M GleiW Schlörmann
Nov 4, 2016·International Journal of Molecular Sciences·Krishant M DeoJanice R Aldrich-Wright
Oct 13, 2017·European Journal of Immunology·Andrea CossarizzaJakob Zimmermann
Dec 19, 2018·Dalton Transactions : an International Journal of Inorganic Chemistry·Leila TabriziOlatomide A Fadare
Feb 7, 2019·Dalton Transactions : an International Journal of Inorganic Chemistry·Vivianne S Velozo-SáElisângela P Silveira-Lacerda
Nov 5, 2016·Oncotarget·Lanmei ChenBilian Xu